NCT00133133View on ClinicalTrials.gov

Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

December 31, 2005

Conditions
Postoperative Pain
Interventions
DRUG

ALGRX 4975

Trial Locations (1)

11000

Emergency Center, Clinical Center of Serbia, Belgrade

Sponsors
All Listed Sponsors
lead

AlgoRx Pharmaceuticals

INDUSTRY

NCT00133133 - Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal | Biotech Hunter | Biotech Hunter